Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins

George F. Widhopf(University of California San Diego), Thomas J. Kipps(University of California San Diego), Laura Z. Rassenti(University of California San Diego), Traci L. Toy(Dana-Farber Cancer Institute), John G. Gribben(Queen Mary University of London), William G. Wierda(The University of Texas MD Anderson Cancer Center)
Blood
June 25, 2004
10.1182/blood-2004-03-0818
Cited by 247

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k